What are the problems of EMA?

Answer 1

The European Medicines Agency (EMA) faces several challenges, including regulatory complexity, which can slow down the approval process for new drugs and therapies. Additionally, it must navigate varying member state interests and healthcare systems, leading to inconsistencies in implementation and access to treatments. Budget constraints and resource limitations can also hinder its ability to conduct comprehensive evaluations and inspections. Lastly, the rapid pace of scientific innovation demands that the EMA continuously adapt its frameworks and processes to ensure timely and effective responses.